“Oncolytic viruses are absolutely harmless (viruses. - RT) and cause the death of specific cancer cells,” he said.
According to him, the tumor in people is “strictly individual, therefore you will not be able to treat different tumors with the same virus.”
“And we have created a panel of these viruses that can help treat various kinds of tumors,” the specialist added.
As Makarov pointed out, in the treatment with this method, targeted delivery of viruses to the cells is used, for which the patient’s immune cells are taken, they are infected with the virus in vitro, and then introduced back into the body.
Being in the cell, the virus is protected from inactivation and can multiply. In this case, the cell itself delivers it to the desired location of the tumor or metastases.
As Makarov said, the effectiveness of this technology is tested on patients with the 4th, terminal, stage of cancer.
In the summer of 2019, it became known that Russian immunologists developed a method for quickly determining the genetic differences between a donor and a recipient in bone marrow transplantation.
As noted, the methodology of domestic experts will help in the treatment of blood cancer.